1. Technical Modifications That Might Improve Long-term Outcomes of the Ross Procedure in Children.
- Author
-
Vricella LA, El-Zein C, Hibino N, Rausa J, Roberson D, and Ilbawi MN
- Subjects
- Adolescent, Aortic Valve Disease diagnosis, Aortic Valve Disease mortality, Autografts, Balloon Valvuloplasty mortality, Child, Child, Preschool, Echocardiography, Transesophageal, Female, Follow-Up Studies, Heart Valve Prosthesis Implantation mortality, Humans, Illinois epidemiology, Infant, Male, Reoperation, Retrospective Studies, Survival Rate trends, Time Factors, Aortic Valve Disease surgery, Balloon Valvuloplasty methods, Heart Valve Prosthesis Implantation methods, Pulmonary Valve transplantation
- Abstract
Background: Failure of the pulmonary valve autograft (PVA) after the Ross procedure (RP) has discouraged its widespread use and has led to modifications or alternatives to the procedure. We sought to analyze whether certain technical modifications could improve results of the RP in children., Methods: Sixty-nine patients (median age, 12 years; range, 0.25-17.9) underwent the RP between January 1996 and December 2018. A concomitant Konno procedure was performed on 20 of 69 patients (29%). Prior interventions included balloon valvuloplasty in 30 (44%) and/or surgical valvuloplasty in 39 (57%). Technical modifications included using the native aortic root for external annuloplasty, implanting the autograft using uniplanar horizontal sutures through the aortic wall, normalizing the sinotubular junction, and wrapping the native root remnant around the PVA., Results: Operative mortality was 1 of 69 patients (1.5%), with no late deaths. No patient had neoaortic valvar stenosis and 7 of 68 (10%) had mild regurgitation on discharge echocardiogram. At latest follow-up (median, 9.4 years; range, 0.4-21.3) there was no significant change in Z scores of annulus, sinus, or sinotubular junction diameters when compared with those at discharge. Three patients (4.4%) required late autograft replacement, 2 PVA repair, and 2 resection of a pseudoaneurysm. Actuarial freedom from PVA replacement was 87% at 20 years. Freedom from right ventricular outflow tract catheter reintervention or reoperation was 83% and 80%, respectively., Conclusions: Technical modifications of the RP used in this cohort might successfully prolong the life of the PVA without compromising its growth, an important advantage in pediatric patients., (Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF